Ally Bridge Group (NY) LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$116.6B
Holdings
30
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ITCIEURINTRA-CELLULAR THERAPIES INC | 147,750 | $12.3B | 10.58% | |
| 2 | TARSTARSUS PHARMACEUTICALS INC | 173,144 | $9.6B | 8.22% | |
| 3 | IM8NINSMED INC | 114,360 | $7.9B | 6.77% | |
| 4 | AXSMAXSOME THERAPEUTICS INC | 66,661 | $5.6B | 4.84% | |
| 5 | XENEXENON PHARMACEUTICALS INC | 129,291 | $5.1B | 4.35% | |
| 6 | CGONCG ONCOLOGY INC | 174,048 | $5.0B | 4.28% | |
| 7 | MRUSMERUS N V | 116,796 | $4.9B | 4.21% | |
| 8 | 2L9BLUEPRINT MEDICINES CORP | 55,892 | $4.9B | 4.18% | |
| 9 | JANXJANUX THERAPEUTICS INC | 90,292 | $4.8B | 4.14% | |
| 10 | CNTACENTESSA PHARMACEUTICALS PLC | 244,538 | $4.1B | 3.51% | |
| 11 | SLNOSOLENO THERAPEUTICS INC | 87,629 | $3.9B | 3.38% | |
| 12 | GONGERON CORP | 1,074,824 | $3.8B | 3.26% | |
| 13 | ALMSALUMIS INC | 445,259 | $3.5B | 3.00% | |
| 14 | PRAXPRAXIS PRECISION MEDICINES I | 44,982 | $3.5B | 2.97% | |
| 15 | TRVITREVI THERAPEUTICS INC | 781,489 | $3.2B | 2.76% | |
| 16 | ELVNENLIVEN THERAPEUTICS INC | 141,710 | $3.2B | 2.73% | |
| 17 | KRROKORRO BIO INC | 70,678 | $2.7B | 2.31% | |
| 18 | JSPRJASPER THERAPEUTICS INC | 122,424 | $2.6B | 2.24% | |
| 19 | EYPTEYEPOINT PHARMACEUTICALS INC | 348,000 | $2.6B | 2.22% | |
| 20 | WHWKAADI BIOSCIENCE INC | 817,939 | $2.6B | 2.21% | |
| 21 | ATYRATYR PHARMA INC | 699,730 | $2.5B | 2.17% | |
| 22 | ETNBGBP89BIO INC | 317,833 | $2.5B | 2.13% | |
| 23 | TYRATYRA BIOSCIENCES INC | 175,063 | $2.4B | 2.09% | |
| 24 | DNTHDIANTHUS THERAPEUTICS INC | 106,434 | $2.3B | 1.99% | |
| 25 | BRD1EURMIND MEDICINE MINDMED INC | 330,275 | $2.3B | 1.97% | |
| 26 | EWTXEDGEWISE THERAPEUTICS INC | 83,176 | $2.2B | 1.90% | |
| 27 | SWTXSPRINGWORKS THERAPEUTICS INC | 54,692 | $2.0B | 1.69% | |
| 28 | CNTXCONTEXT THERAPEUTICS INC | 1,576,762 | $1.7B | 1.42% | |
| 29 | PMNEURPROMIS NEUROSCIENCES INC | 1,592,605 | $1.5B | 1.29% | |
| 30 | CLYMCLIMB BIO INC | 760,225 | $1.4B | 1.17% |